Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on November 25, 2008
JNCI Journal of the National Cancer Institute 2008 100(23):1670-1671; doi:10.1093/jnci/djn428
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
100/23/1670    most recent
djn428v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Twombly, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Twombly, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

NEWS

Adjuvant Chemoradiation for Pancreatic Cancer: Few Good Data, Much Debate

Renee Twombly

The first 150 words of the full text of this article appear below.

Almost a quarter century after the publication of the first American clinical trial comparing chemoradiation with chemotherapy alone after surgery for pancreatic cancer, the debate over which treatment is better persists.

According to those involved, few issues in cancer care are more divisive. Reflecting entrenched positions, practices vary widely in the United States. Some centers don't offer chemoradiation; others throw everything they have against the cancer, including two different chemotherapies with chemoradiation between. There is also a continental divide: Most of the studies that suggested that chemoradiation doesn't work came from Europe, and more institutions there than in the United States use chemotherapy alone.

A self-described "fence sitter" put the issue this way: "The less we know about something, the more firm people's opinions are," said Jordan Berlin, M.D., clinical director of gastrointestinal oncology at Vanderbilt-Ingram Cancer Center in Nashville, Tenn. Berlin, who coauthored an editorial in the July 20 . . . [Full Text of this Article]

Entrenched Views

Europe versus the United States


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
G. Komar, S. Kauhanen, K. Liukko, M. Seppanen, S. Kajander, J. Ovaska, P. Nuutila, and H. Minn
Decreased Blood Flow with Increased Metabolic Activity: A Novel Sign of Pancreatic Tumor Aggressiveness
Clin. Cancer Res., September 1, 2009; 15(17): 5511 - 5517.
[Abstract] [Full Text] [PDF]